Veraxa Biotech Holding AG (VRXA) Operating Leases (2024 - 2025)
Veraxa Biotech Holding AG's (VRXA) quarterly Operating Leases came in at $1.4 million in Q4 2025, up 76.56% year-on-year from $808291.1 in Q4 2024, and up 76.56% on a QoQ basis from $808291.1 in Q4 2024.
Veraxa Biotech Holding AG (VRXA) Operating Leases (2024 - 2025) Analysis & Trends
Veraxa Biotech Holding AG (VRXA) has 2 years of Operating Leases data on file, last reported at $1.4 million in Q4 2025.
- On a quarterly basis, Operating Leases rose 76.56% year-over-year to $1.4 million in Q4 2025; TTM through Dec 2025 was $1.4 million, a 76.56% increase from a year earlier, with the FY2025 full-year figure at $1.4 million, up 76.56% from the prior year.
- Operating Leases for Q4 2025 stood at $1.4 million, up from $808291.1 in the prior quarter.
- Over the last five years, Operating Leases for VRXA reached as high as $1.4 million in Q4 2025 and fell as low as $808291.1 in Q4 2024.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.43 Mn |
| Dec 31, 2024 | 808,291.07 |